Home > Signaling Pathways>Angiogenesis>ALK>BRIGATINIB ANALOG
BRIGATINIB ANALOG

This product is for research use only, not for human use. We do not sell to patients.

BRIGATINIB ANALOG
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
500mg$650Check With Us
1g$1050Check With Us
5g$2660Check With Us

Cat #: V3921 CAS #: 1197958-12-5 Purity ≥ 98%

Description: Brigatinib analog is a derivative of Brigatinib (AP-26113; Alunbrig), which is an orally bioavailable ALK (anaplastic lymphoma kinase) inhibitor approved by FDA in 2017 for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC).

References: Sen Zhang, Frank Wang, Jeffrey Keats, Abstract LB-298: AP26113, a potent ALK inhibitor, overcomes mutations in EML4-ALK that confer resistance to PF-02341066 (PF1066). Cancer Research: April 15, 2010; Volume 70, Issue 8, Supplement 1

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)529.01
Molecular FormulaC26H34ClN6O2P
CAS No.1197958-12-5
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 45 mg/mL (85.1 mM)r
Water: <1 mg/mLr
Ethanol: 106 mg/mL (200.4 mM)
Solubility In VivoNMP+polyethylene glycol 300 (10+90, v+v): 1 mg/mL
SMILES CodeCP(C)(C1=CC=CC=C1NC2=NC(NC3=CC=C(N4CCC(N(C)C)CC4)C=C3OC)=NC=C2Cl)=O
SynonymsAP-26113; Brigatinib-analog; AP26113; AP 26113
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.8903 mL9.4516 mL18.9032 mL37.8065 mL
5mM0.3781 mL1.8903 mL3.7806 mL7.5613 mL
10mM0.1890 mL0.9452 mL1.8903 mL3.7806 mL
20mM0.0945 mL0.4726 mL0.9452 mL1.8903 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.